Herzspezialisten

05/01/2026

Für manche gehört es zu den Zielen für 2026, zumindest einmal 42,195 km zu laufen. Doch wie belastend ist das für das Herz? Umfassende Daten schätzen das Risiko neu ein: https://www.derstandard.at/story/3000000302309/studie-klaert-offene-frage-ob-marathons-laengerfristig-das-herz-schaedigen

02/01/2026

ICYMI: 2025 ACC/AHA/Multisociety on highlights practice-changing recommendations for caring for a diverse ACHD population.

Among the highlights, the guideline emphasizes the importance of access to routine care at ACHD centers and in collaboration with ACHD cardiologists, providing recommendations about when specialized expertise is warranted and how specialists can partner with other clinicians to broaden access to care.

Get the details here ➡️ https://bit.ly/48Z2Mht JACC Journals

31/12/2025

Can cuffless blood pressure (BP) measuring devices change cardiovascular disease prevention and treatment?

Potentially, but research has yet to prove these wearable devices as accurate or reliable enough to do so, according to a scientific statement from the American Heart Association. The scientific statement was published recently in Hypertension. http://ms.spr.ly/6186tsLoM

21/12/2025

🫀 Transcatheter aortic valve implantation in bicuspid aortic valves: present and future

Younger patients, complex anatomy, higher PVL and stroke risk — results still lag behind surgery.
🔗https://secce.es/en/transcatheter-aortic-valve-implantation-in-bicuspid-aortic-valves-present-and-future/

16/12/2025

In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy. https://ja.ma/4pW2n6Z

16/12/2025

Transcatheter edge-to-edge repair in secondary mitral regurgitation: State-of-the-art

This state-of-the-art review provides a comprehensive synthesis of the evidence supporting mitral transcatheter edge-to-edge repair (m-TEER), with a focus on procedural and follow-up outcomes, and clarifies its role in reshaping the therapeutic strategy for patients with heart failure and secondary mitral regurgitation.

https://eurointervention.pcronline.com/article/transcatheter-edge-to-edge-repair-in-secondary-mitral-regurgitation

12/12/2025

Myocardial fibroblast activation in aortic stenosis: progression and response to intervention 👇

12/12/2025

Increased CMR-derived epicardial adipose tissue volume is associated with more extensive acute myocardial injury after myocardial infarction 👇

12/12/2025

Atrial functional mitral regurgitation and exercise-induced changes in heart failure with preserved ejection fraction 👇

06/12/2025

01/12/2025

Bicuspid aortic valve infective endocarditis (BAV-IE) patients incur delayed symptom-to-diagnosis time resulting in high IE complication burden, despite predominance of less virulent streptococcal causative microorganisms. These findings call for enhanced IE clinical suspicion in BAV patients and suggest antibiotic prophylaxis may be indicated in these patients.

Learn more in : https://bit.ly/3MxAbrT